Understanding the impact of distance and disadvantage on lung cancer care and outcomes: a study protocol

Lung cancer is the third most common cancer in the UK and the leading cause of cancer mortality globally. NHS England guidance for optimum lung cancer care recommends management and treatment by a specialist team, with experts concentrated in one place, providing access to specialised diagnostic and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC cancer 2024-08, Vol.24 (1), p.942-9, Article 942
Hauptverfasser: McInnerney, Daisy, Quaife, Samantha L, Cooke, Samuel, Mitchinson, Lucy, Pogson, Zara, Ricketts, William, Januszewski, Adam, Lerner, Anna, Skinner, Dawn, Civello, Sarah, Kane, Ros, Harding-Bell, Ava, Calman, Lynn, Selby, Peter, Peake, Michael D, Nelson, David
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Lung cancer is the third most common cancer in the UK and the leading cause of cancer mortality globally. NHS England guidance for optimum lung cancer care recommends management and treatment by a specialist team, with experts concentrated in one place, providing access to specialised diagnostic and treatment facilities. However, the complex and rapidly evolving diagnostic and treatment pathways for lung cancer, together with workforce limitations, make achieving this challenging. This place-based, behavioural science-informed qualitative study aims to explore how person-related characteristics interact with a person's location relative to specialist services to impact their engagement with the optimal lung pathway, and to compare and contrast experiences in rural, coastal, and urban communities. This study also aims to generate translatable evidence to inform the evidence-based design of a patient engagement intervention to improve lung cancer patients' and informal carers' participation in and experience of the lung cancer care pathway. A qualitative cross-sectional interview study with people diagnosed with lung cancer 
ISSN:1471-2407
1471-2407
DOI:10.1186/s12885-024-12705-9